 RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores
RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26
Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26 Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores
Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores
Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores
Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores 
              Aurobindo Pharma Ltd has announced that pursuant to the applications received for conversion from some of the Bondholders, the Committee of the Board of Directors of the Company at its meeting held on July 11, 2007 has considered the request and allotted 3,74,046 Equity Shares of Rs 5/- each for cash at a premium of Rs 517.036 by conversion of Bonds worth USD 4,500,000 in terms of the offer document to the FCCB holders.
The stock was trading at Rs.745.20, up by Rs.5.25 or 0.71%. The stock hit an intraday high of Rs.753 and low of Rs.735.10. The total traded quantity was 29917 compared to 2 week average of 51528.